The EPS projection of Illumina, Inc. (NASDAQ:ILMN) for quarter ended 2016-09-30 is $0.9. Last week, the projection for EPS was $0.9 against target of $0.9, a month earlier. While 2-months ago, this projection was $0.9 versus forecast of $0.9a quarter months earlier, posting a deviation of 0%.
Illumina, Inc. (NASDAQ:ILMN) posted that 18 days earlier, the share price was revised 1 times on upside. In addition, negative revisions were 7.
In last week, negative EPS revisions were 0 times and positive EPS revisions were 0 times. In last one-month and two month the positive revisions were 0 and 0. While in last 120 and 90 days, positive revisions were 1, and 1, correspondingly.
The per-share earnings downgrade for Illumina, Inc. (NASDAQ:ILMN) in the preceding 30 and 120 were 0 and 8. While in 60 and 90 days were 0, and 8, in that order.
Illumina, Inc. (NASDAQ:ILMN) EPS target was $0.9 for the quarter closed 1. It was based on 13 calls. As on 2016-05-03 the EPS was $0.71. The change was $-0.03, posting a deviation of -4.05%. The price projections gave a standard deviation of 0.04.
Quarterly Sales Estimates
Illumina, Inc. (NASDAQ:ILMN) sales prediction for the fiscal 2017 stands at $772.555 and the median estimate is at $772.555. Almost 2 analysts gave sales target.
Among this, the highest sales estimate is $809.111 while the lowest target is $736 showing standard deviation of 51.697%.
As many as 2 analysts have positive sales targets revision while 2 reduced sales estimates, posting a deviation of 0%.
Last month, 2 experts have positive sales number revision. Also, 2 research groups lowered the sales projections, posting a deviation of 0%.
A quarter ago, 2 hiked sales target and 2 reduced sales forecast, posting a deviation of -3.175%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...